Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27

Y Katayose, M Kim, ANS Rakkar, Z Li, KH Cowan… - Cancer research, 1997 - AACR
Y Katayose, M Kim, ANS Rakkar, Z Li, KH Cowan, P Seth
Cancer research, 1997AACR
Abstract p27Kip1, a cyclin-dependent kinase inhibitor, is recognized as a negative regulator
of the cell cycle. In this paper, we report that overexpression of p27Kip1 triggers apoptosis in
several different human cancer cell lines. Using a recombinant adenoviral vector that
expresses p27Kip1 (Adp27), we found that overexpression of p27Kip1 in MDA-MB-231
breast cancer cells induces apoptosis that was seen by a number of different techniques,
including flow cytometry and in situ terminal deoxynucleotidyl transferase-mediated nick end …
Abstract
p27Kip1, a cyclin-dependent kinase inhibitor, is recognized as a negative regulator of the cell cycle. In this paper, we report that overexpression of p27Kip1 triggers apoptosis in several different human cancer cell lines. Using a recombinant adenoviral vector that expresses p27Kip1 (Adp27), we found that overexpression of p27Kip1 in MDA-MB-231 breast cancer cells induces apoptosis that was seen by a number of different techniques, including flow cytometry and in situ terminal deoxynucleotidyl transferase-mediated nick end labeling, flow cytometric assay for sub-G1 population, and 4′,6-diamindino-2-phenylindole staining. Cleavage of poly-(ADP-ribose) polymerase and degradation of cyclin B1, events that are known to be associated with apoptosis, were also observed following overexpression of p27Kip1. This is the first report indicating a role for p27Kip1 in induction of apoptosis.
AACR